Intrexon | XON - Mitarbeiter Gesamtzahl





Mitarbeiter Veränderung Datum
Agenus 389 144 2023-12
Alaunos Therapeutics 1 33 2023-12
Amgen 28K 1.3K 2024-12
Anika Therapeutics 357 12 2023-12
Arrowhead Research 711 102 2025-12
AstraZeneca USD 89.9K 6.4K 2023-12
Bristol-Myers Squibb 34.1K 0 2024-12
Gilead Sciences 17.6K 400 2024-12
GlaxoSmithKline 69.4K 20.7K 2022-12
Heron Therapeutics 126 77 2023-12
Incyte 2.62K 93 2024-12
Intrexon 202 7 2023-12
Karyopharm Therapeutics 325 60 2023-12
Ligand Pharmaceuticals 68 10 2024-12
MacroGenics 339 18 2023-12
MannKind 407 7 2024-12
Merck 75K 3K 2024-12
Novartis USD 101.7K 2.62K 2022-12
Rigel Pharmaceuticals 147 8 2023-12
Roche Holding 103.61K 2.69K 2022-12
Sangamo BioSciences 405 73 2023-12
Thermo Fisher Scientific 125K 3K 2024-12
Veracyte 824 9 2024-12
Xencor 250 30 2024-12